Skip to content

Drug interactions

Lenacapavir + Ticagrelor

Severity: Moderate

Lenacapavir and Ticagrelor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor, and its long-acting injectable form keeps this effect for months. Ticagrelor exposure may increase, with more bleeding and dyspnea.

What this interaction means in plain words

Lenacapavir and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated ticagrelor metabolism by lenacapavir.

What to do

Monitor for bleeding and dyspnea, remembering that the inhibitory effect persists after the last injection. Consider an alternative antiplatelet if bleeding occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Ticagrelor?

MediHelp rates the interaction as moderate. Lenacapavir and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor, and its long-acting injectable form keeps this effect for months. Ticagrelor exposure may increase, with more bleeding and dyspnea.

How serious is the interaction between Lenacapavir and Ticagrelor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and dyspnea, remembering that the inhibitory effect persists after the last injection. Consider an alternative antiplatelet if bleeding occurs.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in